HCT 0.00% 0.6¢ holista colltech limited

Ann: Clarification - Acceleration of Natshield - Raising of $2.2M, page-90

  1. 12,633 Posts.
    lightbulb Created with Sketch. 526
    "Although it was not specifically stated, this lead shareholders to believe that we were testing against the human strain"

    This is what the company said on the 16th March annoucement...

    “This testing at an approved laboratory in the United Kingdom is an important breakthrough. PathAway® has had success before Covid-19, but in view of the scale and urgency of the problem worldwide caused by Covid-19, we need to obtain verifiable data that Path-Away® kills this
    coronavirus.
    I am personally coordinating with the laboratory which has placed testing of Covid-19 on
    high priority,”

    It's pretty clear that they mentioned they were testing on THIS coronavirus that has killed thousands of people...

    The tests will determine Path-Away®’s efficacy as a sanitiser against Covid-19, the coronavirus that has infected over
    146,000 and killed at least 5,400 people globally as at 13 March 2020. The tests, expected to be
    completed before the end of April 2020


    So IMO there has been a miscommunication
    Last edited by Torbreck: 21/04/20
 
watchlist Created with Sketch. Add HCT (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
0.000(0.00%)
Mkt cap ! $1.673M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $1.591K 265.2K

Buyers (Bids)

No. Vol. Price($)
2 1084379 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 115724 1
View Market Depth
Last trade - 11.57am 21/06/2024 (20 minute delay) ?
HCT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.